Selection of cognitive impairment screening tools for longitudinal implementation in an HIV clinical care setting

References

• Aita, S. L., Kaewpoowat, Q., Yasri, S., Rerkasem, A., Rerkasem, K., Choovuthayakorn, J., Ausayakhun, S., Robertson, K., Roth, R. M., & Robbins, N. M. (2021). Psychometric utility of the international HIV dementia scale and Montreal cognitive assessment in HIV-associated asymptomatic neurocognitive impairment. Journal of Neurovirology, 27(4), 568–578. https://doi.org/10.1007/s13365-021-00991-z
   PubMed Web of Science ®Google Scholar
• Anderson, A. M., Lennox, J. L., Nguyen, M. L., Waldrop-Valverde, D., Tyor, W. R., & Loring, D. W. (2016). Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment. Journal of Neurovirology, 22(6), 816–822. https://doi.org/10.1007/s13365-016-0458-z
   PubMed Web of Science ®Google Scholar
• Becker, J. T., Dew, M. A., Aizenstein, H. J., Lopez, O. L., Morrow, L., & Saxton, J. (2011). Concurrent validity of a computer-based cognitive screening tool for use in adults with HIV disease. AIDS Patient Care and STDs, 25(6), 351–357. https://doi.org/10.1089/apc.2011.0051
   PubMed Web of Science ®Google Scholar
• Calcagno, A., Celani, L., Trunfio, M., Orofino, G., Imperiale, D., Atzori, C., Arena, V., d'Ettorre, G., Guaraldi, G., Gisslen, M., & Di Perri, G. (2021). Alzheimer dementia in people living With HIV. Neurology: Clinical Practice, 11(5), e627–e633. https://doi.org/10.1212/CPJ.0000000000001060
   PubMedGoogle Scholar
• Cogstate. (2022). Computerized Cognitive Assessment Batteries. cogstate.com https://www.cogstate.com/clinical-trials/computerized-cognitive-assessment/featured-batteries/
   Google Scholar
• Cysique, L. A., Maruff, P., Darby, D., & Brew, B. J. (2006). The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Archives of Clinical Neuropsychology, 21(2), 185–194. https://doi.org/10.1016/j.acn.2005.07.011
   PubMed Web of Science ®Google Scholar
• Herrmann, S. R. BSc, MSc, PhD*, McKinnon, E. P., Skinner, M. M. FRACP, Duracinsky, M. M. PhD, Chaney, R. M., Locke, V. M. PhD, & Mastaglia, F MBBS, MD, FRACP, FRCP. (2019). Screening for HIV-associated neurocognitive impairment relevance of psychological factors and Era of commencement of antiretroviral therapy. Journal of the Association of Nurses in AIDS Care, 30(1), 42–50. https://doi.org/10.1097/JNC.0000000000000040
   PubMed Web of Science ®Google Scholar
• HIV and the Older Person: NIH. (2019, December 18). Retrieved October 19, 2022, from https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/hiv-and-older-person
   Google Scholar
• Joly, H., Vassallo, M., Issaurat, M., Fabre, R., Pradier, C., & Lebrun-Frenay, C. (2020). Validation of a rapid and easy-to-perform screening test for neurocognitive impairment in HIV+ patients. Journal of the Neurological Sciences, 410, 116664. https://doi.org/10.1016/j.jns.2019.116664
   PubMed Web of Science ®Google Scholar
• Joska, J. A., Witten, J., Thomas, K. G., Robertson, C., Casson-Crook, M., Roosa, H., Creighton, J., Lyons, J., McArthur, J., & Sacktor, N. C. (2016). A comparison of five brief screening tools for HIV-associated neurocognitive disorders in the USA and South Africa. AIDS and Behavior, 20(8), 1621–1631. https://doi.org/10.1007/s10461-016-1316-y
   PubMed Web of Science ®Google Scholar
• Kamminga, J., Cysique, L. A., Lu, G., Batchelor, J., & Brew, B. J. (2013). Validity of cognitive screens for HIV-associated neurocognitive disorder: A systematic review and an informed screen selection guide. Current HIV/AIDS Reports, 10(4), 342–355. https://doi.org/10.1007/s11904-013-0176-6
   PubMed Web of Science ®Google Scholar
• Kolson, D., & Buch, S. (2013). More than two HANDs to tango. Journal of Neuroimmune Pharmacology, 8(5), 1051–1054. https://doi.org/10.1007/s11481-013-9513-1
   PubMed Web of Science ®Google Scholar
• Kranick, S. M., & Nath, A. (2012 Dec). Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. Continuum (Minneap Minn), 18(6 Infectious Disease), 1319–1337. https://doi.org/10.1212/01.CON.0000423849.24900.ec
   PubMedGoogle Scholar
• Lee, M. T., Jang, Y., & Chang, W. Y. (2019). How do impairments in cognitive functions affect activities of daily living functions in older adults? PloS One, 14(6), e0218112. https://doi.org/10.1371/journal.pone.0218112
   PubMed Web of Science ®Google Scholar
• Maruff, P., Thomas, E., Cysique, L., Brew, B., Collie, A., Snyder, P., & Pietrzak, R. H. (2009). Validity of the CogState brief battery: Relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Archives of Clinical Neuropsychology, 24(2), 165–178. https://doi.org/10.1093/arclin/acp010
   PubMed Web of Science ®Google Scholar
• MoCA Cognitive Assessment - Digital Tools. (2022). mocatest.org. https://www.mocatest.org/digitaltools/
   Google Scholar
• Mwangala, P. N., Newton, C. R., Abas, M., & Abubakar, A. (2018). Screening tools for HIV-associated neurocognitive disorders among adults living with HIV in sub-Saharan Africa: A scoping review. AAS Open Research, 1, 28. https://doi.org/10.12688/aasopenres.12921.2
   PubMedGoogle Scholar
• National HIV/AIDS Strategy (2022-2025). (2021). HIV.gov. https://www.hiv.gov/federal-response/national-hiv-aids-strategy/national-hiv-aids-strategy-2022-2025
   Google Scholar
• Nightingale, S., & Winston, A. (1992). Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS (London, England), 31( Suppl 2), S165–S172. https://doi.org/10.1097/00002030-199202000-00008
   Google Scholar
• NIH toolbox. Nation Institute on Aging. https://www.nia.nih.gov/research/resource/nih-toolbox
   Google Scholar
• Nweke, M., Nombeko, M., Govender, N., Akinpelu, A., & Ogunniyi, A. (2022). Aerobic exercise in HIV-associated neurocognitive disorders: Protocol for a randomized controlled trial. JMIR Research Protocols, 11(1), e29230. https://doi.org/10.2196/29230
   PubMedGoogle Scholar
• Robbins, R. N., Brown, H., Ehlers, A., Joska, J. A., Thomas, K. G., Burgess, R., Byrd, D., & Morgello, S. (2014). A smartphone App to screen for HIV-related neurocognitive impairment. Journal of Mobile Technology in Medicine, 3(1), 23–36. https://doi.org/10.7309/jmtm.3.1.5
   PubMedGoogle Scholar
• Rosca, E. C., Albarqouni, L., & Simu, M. (2019). Montreal cognitive assessment (MoCA) for HIV-associated neurocognitive disorders. Neuropsychology Review, 29(3), 313–327. https://doi.org/10.1007/s11065-019-09412-9
   PubMed Web of Science ®Google Scholar
• Rubin, L. H., Severson, J., Marcotte, T. D., Savin, M. J., Best, A., Johnson, S., Cosman, J., Merickel, M., Buchholz, A., Del Bene, V. A., Eldred, L., Sacktor, N. C., Fuchs, J. B., Althoff, K. N., & Moore, R. D. (2021). Tablet-Based cognitive impairment screening for adults with HIV seeking clinical care: Observational study. JMIR Mental Health, 8(9), e25660. https://doi.org/10.2196/25660
   PubMed Web of Science ®Google Scholar
• Sacktor, N. C., Wong, M., Nakasujja, N., Skolasky, R. L., Selnes, O. A., Musisi, S., Robertson, K., McArthur, J. C., Ronald, A., & Katabira, E. (2005). The international HIV dementia scale: A new rapid screening test for HIV dementia. AIDS (London, England), 19(13), 1367–1374.
   PubMed Web of Science ®Google Scholar
• Saylor, D., Dickens, A. M., Sacktor, N., Haughey, N., Slusher, B., Pletnikov, M., Mankowski, J. L., Brown, A., Volsky, D. J., & McArthur, J. C. (2016). HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment. Nature Reviews Neurology, 12(4), 234–248. https://doi.org/10.1038/nrneurol.2016.27
   PubMed Web of Science ®Google Scholar
• Skinner, S., Adewale, A. J., DeBlock, L., Gill, M. J., & Power, C. (2009). Neurocognitive screening tools in HIV/AIDS: Comparative performance among patients exposed to antiretroviral therapy. HIV Medicine, 10(4), 246–252. https://doi.org/10.1111/j.1468-1293.2008.00679.x
   PubMed Web of Science ®Google Scholar
• Uwishema, O., Ayoub, G., Badri, R., Onyeaka, H., Berjaoui, C., Karabulut, E., Anis, H., Sammour, C., Mohammed Yagoub, F. E. A., & Chalhoub, E. (2022). Neurological disorders in HIV: Hope despite challenges. Immunity, Inflammation and Disease. 10(3), e591. https://doi.org/10.1002/iid3.591.
   Google Scholar
• Wilson, S., Milanini, B., Javandel, S., Nyamayaro, P., & Valcour, V. (2021). Validity of digital assessments in screening for HIV-related cognitive impairment: A review. Current HIV/AIDS Reports, 18(6), 581–592. https://doi.org/10.1007/s11904-021-00585-8
   PubMed Web of Science ®Google Scholar
• Zgaljardic, D. J., & Temple, R. O. (2010). Neuropsychological assessment battery (NAB): performance in a sample of patients with moderate-to-severe traumatic brain injury. Applied Neuropsychology, 17(4), 283–288. https://doi.org/10.1080/09084282.2010.525118
   PubMed Web of Science ®Google Scholar
• Zipursky, A. R., Gogolishvili, D., Rueda, S., Brunetta, J., Carvalhal, A., McCombe, J. A., Gill, M. J., Rachlis, A., Rosenes, R., Arbess, G., Marcotte, T., & Rourke, S. B. (2013). Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS. AIDS (London, England), 27(15), 2385–2401. https://doi.org/10.1097/QAD.0b013e328363bf56
   PubMed Web of Science ®Google Scholar